analyze & realize
  • About a&r
    • Introduction
    • News
    • Publications
    • Careers
    • Contact us
  • Regulatory Consulting
    • Food and Dietary Supplements
    • OTC Drug Products
    • Medical Devices
    • Cosmetics
  • Strategic Innovation & Licensing
    • Strategic Consulting
    • Innovation
    • Market Analysis
    • Licensing
  • Clinical Research
    • Clinical Trials
    • Indications
    • Clinical Research Consulting
    • Study Center
  • Digital Trials
    • Key features
    • How it works
    • Case study
Select Page
EFSA positive opinion on the safety of mung bean protein as a novel food pursuant to Regulation (EU) 2015/2283

EFSA positive opinion on the safety of mung bean protein as a novel food pursuant to Regulation (EU) 2015/2283

Oct 28, 2021 | a&r News, Regulatory

The novel food application for mung bean protein got a positive opinion from EFSA.  Mung bean protein from Eat Just is the first example of a legume protein isolate that passed EFSA’s safety assessment...

Recent Posts

  • Meet us at VLB Symposium in Berlin
  • Meet us at Vitafoods
  • a&r publishes a successful clinical trial on Acacia gum
  • Useful advice on food allergen management
  • Scientific advice on nutrition profiling

Categories

  • a&r News
  • Clinical
  • M&A
  • Market
  • Regulatory
  • Webinars

Copyright a&r 2021 • All Rights Reserved

  • About a&r
  • Regulatory Consulting
  • Strategic Innovation & Licensing
  • Clinical Research
  • Imprint
  • Terms & Conditions
  • Data Protection

Follow us

  • Follow
  • Follow
  • About a&r
  • Regulatory Consulting
  • Strategic Innovation & Licensing
  • Clinical Research
  • Imprint
  • Terms & Conditions
  • Data Protection

Follow us

  • Follow
  • Follow

Copyright a&r 2021 • All Rights Reserved